Discovery and biology of IL-23 and IL-27: Related but functionally distinct regulators of inflammation

被引:630
作者
Kastelein, Robert A. [1 ]
Hunter, Christopher A.
Cua, Daniel J.
机构
[1] Schering Plough Biopharma, Discovery Res, Palo Alto, CA 94304 USA
[2] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA
关键词
innate immunity; autoimmunity; host defense;
D O I
10.1146/annurev.immunol.22.012703.104758
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Long-term resistance to many infections depends on the innate ability of the immune system to coordinate the development of antigen-specific adaptive responses. Deficiencies in these events can result in increased susceptibility to pathogens, whereas an inability to regulate an appropriate response can lead to devastating pathological conditions. For over a decade, interleukin (IL)-12 has been recognized as the canonical cytokine that links innate and adaptive immunity, and with the discovery of IL-23 and IL-27 as cytokines related to IL-12, there has been a concerted effort to understand the relationship between these factors. The results emerging from these studies have provided fundamental new insights into the developmental pathways that promote the differentiation and function of CD4(+) T helper cells and offer a dramatically altered perspective on the cause and prevention of autoimmune disease. In this review, we aim to highlight the discoveries that have led to our current understanding of the biology of IL-23 and IL-27 in the context of their role in resistance to infection, immune-mediated inflammation, and cancer.
引用
收藏
页码:221 / 242
页数:22
相关论文
共 86 条
[1]
Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 [J].
Aggarwal, S ;
Ghilardi, N ;
Xie, MH ;
de Sauvage, FJ ;
Gurney, AL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) :1910-1914
[2]
Cutting edge:: Early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infection [J].
Artis, D ;
Johnson, LM ;
Joyce, K ;
Saris, C ;
Villarino, A ;
Hunter, CA ;
Scott, P .
JOURNAL OF IMMUNOLOGY, 2004, 172 (08) :4672-4675
[3]
The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity [J].
Artis, D ;
Villarino, A ;
Silverman, M ;
He, WM ;
Thornton, EM ;
Mu, S ;
Summer, S ;
Covey, TM ;
Huang, E ;
Yoshida, H ;
Koretzky, G ;
Goldschmidt, M ;
Wu, GD ;
de Sauvage, F ;
Miller, HRP ;
Saris, CJM ;
Scott, P ;
Hunter, CA .
JOURNAL OF IMMUNOLOGY, 2004, 173 (09) :5626-5634
[4]
Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[5]
WSX-1: A key role in induction of chronic intestinal nematode infection [J].
Bancroft, AJ ;
Humphreys, NE ;
Worthington, JJ ;
Yoshida, H ;
Grencis, RK .
JOURNAL OF IMMUNOLOGY, 2004, 172 (12) :7635-7641
[6]
Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells [J].
Batten, Marcel ;
Li, Ji ;
Yi, Sothy ;
Kljavin, Noelyn M. ;
Danilenko, Dimitry M. ;
Lucas, Sophie ;
Lee, James ;
de Sauvage, Frederic J. ;
Ghilardi, Nico .
NATURE IMMUNOLOGY, 2006, 7 (09) :929-936
[7]
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[8]
Neutralization or absence of the interleukin-23 pathway does not compromise immunity to mycobacterial infection [J].
Chackerian, Alissa A. ;
Chen, Shi-Juan ;
Brodie, Scott J. ;
Mattson, Jeanine D. ;
McClanahan, Terrill K. ;
Kastelein, Robert A. ;
Bowman, Edward P. .
INFECTION AND IMMUNITY, 2006, 74 (11) :6092-6099
[9]
Chen JB, 2001, PROG CHEM, V13, P376
[10]
Which arteriovenous malformations should be given ablative treatment? [J].
Chen, M ;
Caplan, LR .
NATURE CLINICAL PRACTICE NEUROLOGY, 2006, 2 (01) :2-3